Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
04/20/2011 | CN1930190B Hyaluronic acid derivative and drug containing the same |
04/20/2011 | CN1928111B Correlation analysis of circulation endothelium progenitor cell and coronary artery pathological changes |
04/20/2011 | CN1909929B Anti-inflammatory analgesic for external use |
04/20/2011 | CN1901896B Use of selected amino acid-zinc complexes as anti-malarials |
04/20/2011 | CN1628179B Detection of hepatocellular carcinoma |
04/20/2011 | CN102026987A Therapeutic agent for pain |
04/20/2011 | CN102026672A C2ORF18 as target gene for cancer therapy and diagnosis |
04/20/2011 | CN102026661A Nutrient composition capable of adjusting energy amount, water amount and salt equivalent |
04/20/2011 | CN102026645A Oncolytic rhabdovirus |
04/20/2011 | CN102026641A Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form |
04/20/2011 | CN102026640A sGC stimulators, sGC activators and combinations thereof for the treatment of hearing impairment |
04/20/2011 | CN102018959A Method and reagent for preventing and treating heart disease |
04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
04/20/2011 | CN102018693A Topical co-enzyme q10 formulations and methods of use |
04/20/2011 | CN102018672A Freeze-dried liposome composition of water-soluble medicament and preparation method thereof |
04/20/2011 | CN102018670A Anticancer preparation and preparation method thereof |
04/20/2011 | CN102018667A Imidazoles antifungal skin wiping agent and preparation method thereof |
04/20/2011 | CN102018658A Controlled release preparation and preparation method thereof |
04/20/2011 | CN102018657A Solid dispersoid containing progestational hormone, preparation method thereof and composite comprising same |
04/20/2011 | CN101530618B Pharmaceutical composition for the treatment of chronic obstructive pulmonary disease and bronchial asthma |
04/20/2011 | CN101502484B Glucocorticosteroid and chemotherapy medicament carried by anticancer sustained-release agent |
04/20/2011 | CN101254305B Composite nasal cavity preparations for curing allergic rhinitis |
04/20/2011 | CN101224306B Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof |
04/19/2011 | US7928206 Pharmaceutical composition comprising a thymidine kinase polynucleotide |
04/19/2011 | US7928146 Topical applying adrenergic blocking agent, nitric oxide synthase inhibitor, prostaglandin, dopamine, morphine and 5-hydroxytryptamine; topical applying |
04/19/2011 | US7928128 Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
04/19/2011 | US7928086 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
04/19/2011 | US7928081 Combined use of PRAME inhibitors and HDAC inhibitors |
04/19/2011 | US7928074 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders |
04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
04/19/2011 | US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
04/19/2011 | US7927627 Nanoparticulate fibrate formulations |
04/19/2011 | US7927612 Combinations and methods for treating neoplasms |
04/19/2011 | US7927606 Modified free-living microbes, vaccine compositions and methods of use thereof |
04/19/2011 | US7927600 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
04/19/2011 | US7927365 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
04/19/2011 | US7927364 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
04/19/2011 | CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
04/19/2011 | CA2458452C Gnrh agonist combination drugs |
04/19/2011 | CA2440557C Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof |
04/19/2011 | CA2400969C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine |
04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
04/19/2011 | CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
04/19/2011 | CA2220116C Dna encoding glutamate gated chloride channels |
04/14/2011 | WO2011044122A1 Compositions and methods of treatment that include plant extracts |
04/14/2011 | WO2011043435A1 Therapeutic agent for influenza virus infectious diseases |
04/14/2011 | WO2011042565A2 Antiprotozoal activity |
04/14/2011 | WO2010120649A3 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation |
04/14/2011 | WO2010031832A9 Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative |
04/14/2011 | WO2010012733A9 Use of a cdk inhibitor for the treatment of glioma |
04/14/2011 | US20110086926 Disabling thymus gland as a new method for treatment of multiple sclerosis |
04/14/2011 | US20110086917 Use of l-carnitine for the treatment of cardiovascular diesases |
04/14/2011 | US20110086907 Acne treatment |
04/14/2011 | US20110086826 Liposomal camptothecins and uses thereof |
04/14/2011 | US20110086821 Tetracycline Compounds for Treatment of Cryptosporidium Parvum Related Disorders |
04/14/2011 | US20110086119 Preparation for the relief of disease |
04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
04/14/2011 | US20110083991 Hyaluronic acid derivative and drug containing the same |
04/13/2011 | EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis |
04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
04/13/2011 | EP2308893A1 Potassium channel mutants of S. cerevisiae and their use for the screening of eucaryotic potassium channels |
04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
04/13/2011 | EP2308515A1 Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors |
04/13/2011 | EP2308510A1 Agent for regeneration and/or protection of nerves |
04/13/2011 | EP2308509A1 Inhibitor of analgesic tolerance |
04/13/2011 | EP2308479A2 Compounds and compositions for delivering active agents |
04/13/2011 | EP2308476A1 Colonic purgative composition with soluble binding agent |
04/13/2011 | EP2308473A1 Pharmaceutical composition containing surface-coated microparticles |
04/13/2011 | EP2307053A2 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug |
04/13/2011 | EP2307052A2 Anti-beta-2-microglobulin agents and the use thereof |
04/13/2011 | EP2307040A1 Method and means for treating viral disease, in particular hiv/aids |
04/13/2011 | EP2307033A2 Use of oncolytic herpes viruses for killing cancer stem cells |
04/13/2011 | EP2307027A1 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
04/13/2011 | EP2307016A2 A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate |
04/13/2011 | EP2307010A1 Thiazole compounds, and compositions and methods using same |
04/13/2011 | EP2307002A1 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine |
04/13/2011 | EP2307000A1 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders |
04/13/2011 | EP2306999A2 Compositions for treating rosacea |
04/13/2011 | EP2306998A1 Pharmaceutical formulation |
04/13/2011 | EP2306836A1 Bmi-1 protein expression modulators |
04/13/2011 | EP2205279B1 Pharmaceutical combination of aliskiren and valsartan |
04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
04/13/2011 | CN1958568B A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application |
04/13/2011 | CN1956726B Composition and method for releasing mammal inflammation and oxidation stress |
04/13/2011 | CN1874774B Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
04/13/2011 | CN1839806B Methods for in vivo delivery of biologics and compositions useful therefor |
04/13/2011 | CN102014960A Pharmaceutical composition based on hepatoprotector and prebiotic, the production and use thereof |
04/13/2011 | CN102014913A Combination therapy with C-MET and EGFR antagonists |
04/13/2011 | CN102014895A Combination anti-cancer agents |
04/13/2011 | CN102014889A Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
04/13/2011 | CN102008730A Transdermal medicine composition and transdermal medicine kit |
04/13/2011 | CN102008726A Dexiburofen amino acid salt-containing medicament for colds |
04/13/2011 | CN102008725A Application of human UTP14a expression inhibitor to preparation of cell proliferation inhibitor |
04/13/2011 | CN102008724A Method and reagent for inhibiting hepatocellular carcinoma |